LUNDBECK PHARMA A/S: Financial statements 2018
CVR: 56750215
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 18,357,000 and a net result of DKK 736,000 compared with DKK 365,000 the year before. That is a decrease of 6.7% compared with the year before. The profit margin was 4%. Equity in the 2018 report amounted to DKK 3,773,000. The solvency ratio was 30.5%. The company had 18 employees in the financial year.
- Revenue
- DKK 18,357,000
- Gross Profit
- DKK 1,686,000
- Profit/Loss
- DKK 736,000
- Equity
- DKK 3,773,000
- Total Assets
- DKK 12,374,000
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 18.4 mio. | 1.7 mio. | 736 t. | 3.8 mio. | 18 |
| 2017 | 19.7 mio. | 764 t. | 365 t. | 3.3 mio. | 14 |
| 2016 | 20.8 mio. | 2.3 mio. | 48 t. | 3 mio. | 8 |
| 2015 | 27 mio. | 4.9 mio. | -129 t. | 3 mio. | - |
| 2014 | 27.7 mio. | 3.3 mio. | 184 t. | 3.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
LUNDBECK PHARMA A/S has published its annual report for 2017. Revenue came to DKK 19,675,000, and the net result was DKK 365,000.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 18 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.